tradingkey.logo

Mangoceuticals Inc

MGRX
View Detailed Chart
1.825USD
+0.025+1.39%
Market hours ETQuotes delayed by 15 min
19.43MMarket Cap
LossP/E TTM

Mangoceuticals Inc

1.825
+0.025+1.39%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.39%

5 Days

-11.84%

1 Month

-19.60%

6 Months

+8.63%

Year to Date

-24.59%

1 Year

-23.00%

View Detailed Chart

TradingKey Stock Score of Mangoceuticals Inc

Currency: USD Updated: 2025-11-04

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. The company shows very weak stock market performance, in line with its fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Mangoceuticals Inc's Score

Industry at a Glance

Industry Ranking
63 / 78
Overall Ranking
487 / 4616
Industry
Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Mangoceuticals Inc Highlights

StrengthsRisks
Mangoceuticals, Inc. is primarily focused on developing, marketing, and selling a variety of men’s health and wellness products and services via a secure telemedicine platform. The Company has developed and is commercially marketing a new brand of erectile dysfunction (ED) products under the brand name Mango and a brand of hair loss products under the brand name Grow. These products are produced at a compounding pharmacy using a proprietary combination of United States Food and Drug Administration (FDA) approved ingredients and are available to patients on the determination of a prescribing physician that the compounded drug is necessary for the individual patient. It is marketing and selling these branded ED and hair loss products exclusively online via its Website at www.MangoRx.com. Its customer platform connects consumers to licensed healthcare professionals through its Website for the provision of care via telehealth. It also owns a global patent portfolio of oral solution.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 6789.73% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 615.87K.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 615.87K.
Fairly Valued
The company’s latest PE is -0.62, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 292.25K shares, increasing 33.05% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 31.00K shares of this stock.

Mangoceuticals Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Mangoceuticals Inc Info

Mangoceuticals, Inc. is primarily focused on developing, marketing, and selling a variety of men’s health and wellness products and services via a secure telemedicine platform. The Company has developed and is commercially marketing a new brand of erectile dysfunction (ED) products under the brand name Mango and a brand of hair loss products under the brand name Grow. These products are produced at a compounding pharmacy using a proprietary combination of United States Food and Drug Administration (FDA) approved ingredients and are available to patients on the determination of a prescribing physician that the compounded drug is necessary for the individual patient. It is marketing and selling these branded ED and hair loss products exclusively online via its Website at www.MangoRx.com. Its customer platform connects consumers to licensed healthcare professionals through its Website for the provision of care via telehealth. It also owns a global patent portfolio of oral solution.
Ticker SymbolMGRX
CompanyMangoceuticals Inc
CEOMr. Jacob D. Cohen
Websitehttps://www.mangorx.com/
KeyAI